Microwave Thermotherapy: New treatment for cutaneous leishmaniasis

Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishman...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Khalifa E. Sharquie [verfasserIn] Sabeeh A. Al-Mashhadani [verfasserIn] Adil A. Noaimi [verfasserIn] Wasan B. Al-Zoubaidi [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch ; Spanisch ; Französisch ; Polnisch

Erschienen:	2015

Schlagwörter:	Cutaneous leishmaniasis; Thermotherapy; Microwave

Übergeordnetes Werk:	In: Nasza Dermatologia Online - Our Dermatology Online, 2011, 6(2015), 2, Seite 125-129
Übergeordnetes Werk:	volume:6 ; year:2015 ; number:2 ; pages:125-129

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.7241/ourd.20152.34

Katalog-ID:	DOAJ065895401

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ065895401
003	DE-627
005	20230309053933.0
007	cr uuu---uuuuu
008	230228s2015 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.7241/ourd.20152.34 \|2 doi
035			\|a (DE-627)DOAJ065895401
035			\|a (DE-599)DOAJcb2fe83f000a443cb8fa9d3c25b45866
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng \|a spa \|a fre \|a pol
050		0	\|a RL1-803
100	0		\|a Khalifa E. Sharquie \|e verfasserin \|4 aut
245	1	0	\|a Microwave Thermotherapy: New treatment for cutaneous leishmaniasis
264		1	\|c 2015
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects.
650		4	\|a Cutaneous leishmaniasis; Thermotherapy; Microwave
653		0	\|a Dermatology
700	0		\|a Sabeeh A. Al-Mashhadani \|e verfasserin \|4 aut
700	0		\|a Adil A. Noaimi \|e verfasserin \|4 aut
700	0		\|a Wasan B. Al-Zoubaidi \|e verfasserin \|4 aut
773	0	8	\|i In \|t Nasza Dermatologia Online \|d Our Dermatology Online, 2011 \|g 6(2015), 2, Seite 125-129 \|w (DE-627)1760606286 \|x 20819390 \|7 nnns
773	1	8	\|g volume:6 \|g year:2015 \|g number:2 \|g pages:125-129
856	4	0	\|u https://doi.org/10.7241/ourd.20152.34 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/cb2fe83f000a443cb8fa9d3c25b45866 \|z kostenfrei
856	4	0	\|u http://www.odermatol.com/issue-in-html/2015-2-1/ \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2081-9390 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 6 \|j 2015 \|e 2 \|h 125-129

Indexfelder

author_variant	k e s kes s a a m saam a a n aan w b a z wbaz
matchkey_str	article:20819390:2015----::irwvtemteayetetetoctn
hierarchy_sort_str	2015
callnumber-subject-code	RL
publishDate	2015
allfields	10.7241/ourd.20152.34 doi (DE-627)DOAJ065895401 (DE-599)DOAJcb2fe83f000a443cb8fa9d3c25b45866 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Khalifa E. Sharquie verfasserin aut Microwave Thermotherapy: New treatment for cutaneous leishmaniasis 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects. Cutaneous leishmaniasis; Thermotherapy; Microwave Dermatology Sabeeh A. Al-Mashhadani verfasserin aut Adil A. Noaimi verfasserin aut Wasan B. Al-Zoubaidi verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 6(2015), 2, Seite 125-129 (DE-627)1760606286 20819390 nnns volume:6 year:2015 number:2 pages:125-129 https://doi.org/10.7241/ourd.20152.34 kostenfrei https://doaj.org/article/cb2fe83f000a443cb8fa9d3c25b45866 kostenfrei http://www.odermatol.com/issue-in-html/2015-2-1/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 6 2015 2 125-129
spelling	10.7241/ourd.20152.34 doi (DE-627)DOAJ065895401 (DE-599)DOAJcb2fe83f000a443cb8fa9d3c25b45866 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Khalifa E. Sharquie verfasserin aut Microwave Thermotherapy: New treatment for cutaneous leishmaniasis 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects. Cutaneous leishmaniasis; Thermotherapy; Microwave Dermatology Sabeeh A. Al-Mashhadani verfasserin aut Adil A. Noaimi verfasserin aut Wasan B. Al-Zoubaidi verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 6(2015), 2, Seite 125-129 (DE-627)1760606286 20819390 nnns volume:6 year:2015 number:2 pages:125-129 https://doi.org/10.7241/ourd.20152.34 kostenfrei https://doaj.org/article/cb2fe83f000a443cb8fa9d3c25b45866 kostenfrei http://www.odermatol.com/issue-in-html/2015-2-1/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 6 2015 2 125-129
allfields_unstemmed	10.7241/ourd.20152.34 doi (DE-627)DOAJ065895401 (DE-599)DOAJcb2fe83f000a443cb8fa9d3c25b45866 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Khalifa E. Sharquie verfasserin aut Microwave Thermotherapy: New treatment for cutaneous leishmaniasis 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects. Cutaneous leishmaniasis; Thermotherapy; Microwave Dermatology Sabeeh A. Al-Mashhadani verfasserin aut Adil A. Noaimi verfasserin aut Wasan B. Al-Zoubaidi verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 6(2015), 2, Seite 125-129 (DE-627)1760606286 20819390 nnns volume:6 year:2015 number:2 pages:125-129 https://doi.org/10.7241/ourd.20152.34 kostenfrei https://doaj.org/article/cb2fe83f000a443cb8fa9d3c25b45866 kostenfrei http://www.odermatol.com/issue-in-html/2015-2-1/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 6 2015 2 125-129
allfieldsGer	10.7241/ourd.20152.34 doi (DE-627)DOAJ065895401 (DE-599)DOAJcb2fe83f000a443cb8fa9d3c25b45866 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Khalifa E. Sharquie verfasserin aut Microwave Thermotherapy: New treatment for cutaneous leishmaniasis 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects. Cutaneous leishmaniasis; Thermotherapy; Microwave Dermatology Sabeeh A. Al-Mashhadani verfasserin aut Adil A. Noaimi verfasserin aut Wasan B. Al-Zoubaidi verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 6(2015), 2, Seite 125-129 (DE-627)1760606286 20819390 nnns volume:6 year:2015 number:2 pages:125-129 https://doi.org/10.7241/ourd.20152.34 kostenfrei https://doaj.org/article/cb2fe83f000a443cb8fa9d3c25b45866 kostenfrei http://www.odermatol.com/issue-in-html/2015-2-1/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 6 2015 2 125-129
allfieldsSound	10.7241/ourd.20152.34 doi (DE-627)DOAJ065895401 (DE-599)DOAJcb2fe83f000a443cb8fa9d3c25b45866 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Khalifa E. Sharquie verfasserin aut Microwave Thermotherapy: New treatment for cutaneous leishmaniasis 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects. Cutaneous leishmaniasis; Thermotherapy; Microwave Dermatology Sabeeh A. Al-Mashhadani verfasserin aut Adil A. Noaimi verfasserin aut Wasan B. Al-Zoubaidi verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 6(2015), 2, Seite 125-129 (DE-627)1760606286 20819390 nnns volume:6 year:2015 number:2 pages:125-129 https://doi.org/10.7241/ourd.20152.34 kostenfrei https://doaj.org/article/cb2fe83f000a443cb8fa9d3c25b45866 kostenfrei http://www.odermatol.com/issue-in-html/2015-2-1/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 6 2015 2 125-129
language	English Spanish French Polish
source	In Nasza Dermatologia Online 6(2015), 2, Seite 125-129 volume:6 year:2015 number:2 pages:125-129
sourceStr	In Nasza Dermatologia Online 6(2015), 2, Seite 125-129 volume:6 year:2015 number:2 pages:125-129
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Cutaneous leishmaniasis; Thermotherapy; Microwave Dermatology
isfreeaccess_bool	true
container_title	Nasza Dermatologia Online
authorswithroles_txt_mv	Khalifa E. Sharquie @@aut@@ Sabeeh A. Al-Mashhadani @@aut@@ Adil A. Noaimi @@aut@@ Wasan B. Al-Zoubaidi @@aut@@
publishDateDaySort_date	2015-01-01T00:00:00Z
hierarchy_top_id	1760606286
id	DOAJ065895401
language_de	englisch spanisch franzoesisch polnisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ065895401</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309053933.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7241/ourd.20152.34</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ065895401</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJcb2fe83f000a443cb8fa9d3c25b45866</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">spa</subfield><subfield code="a">fre</subfield><subfield code="a">pol</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RL1-803</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Khalifa E. Sharquie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Microwave Thermotherapy: New treatment for cutaneous leishmaniasis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cutaneous leishmaniasis; Thermotherapy; Microwave</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Dermatology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sabeeh A. Al-Mashhadani</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Adil A. Noaimi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wasan B. Al-Zoubaidi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nasza Dermatologia Online</subfield><subfield code="d">Our Dermatology Online, 2011</subfield><subfield code="g">6(2015), 2, Seite 125-129</subfield><subfield code="w">(DE-627)1760606286</subfield><subfield code="x">20819390</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:6</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:125-129</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.7241/ourd.20152.34</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/cb2fe83f000a443cb8fa9d3c25b45866</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.odermatol.com/issue-in-html/2015-2-1/</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2081-9390</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">6</subfield><subfield code="j">2015</subfield><subfield code="e">2</subfield><subfield code="h">125-129</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Khalifa E. Sharquie
spellingShingle	Khalifa E. Sharquie misc RL1-803 misc Cutaneous leishmaniasis; Thermotherapy; Microwave misc Dermatology Microwave Thermotherapy: New treatment for cutaneous leishmaniasis
authorStr	Khalifa E. Sharquie
ppnlink_with_tag_str_mv	@@773@@(DE-627)1760606286
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RL1-803
illustrated	Not Illustrated
issn	20819390
topic_title	RL1-803 Microwave Thermotherapy: New treatment for cutaneous leishmaniasis Cutaneous leishmaniasis; Thermotherapy; Microwave
topic	misc RL1-803 misc Cutaneous leishmaniasis; Thermotherapy; Microwave misc Dermatology
topic_unstemmed	misc RL1-803 misc Cutaneous leishmaniasis; Thermotherapy; Microwave misc Dermatology
topic_browse	misc RL1-803 misc Cutaneous leishmaniasis; Thermotherapy; Microwave misc Dermatology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Nasza Dermatologia Online
hierarchy_parent_id	1760606286
hierarchy_top_title	Nasza Dermatologia Online
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1760606286
title	Microwave Thermotherapy: New treatment for cutaneous leishmaniasis
ctrlnum	(DE-627)DOAJ065895401 (DE-599)DOAJcb2fe83f000a443cb8fa9d3c25b45866
title_full	Microwave Thermotherapy: New treatment for cutaneous leishmaniasis
author_sort	Khalifa E. Sharquie
journal	Nasza Dermatologia Online
journalStr	Nasza Dermatologia Online
callnumber-first-code	R
lang_code	eng spa fre pol
isOA_bool	true
recordtype	marc
publishDateSort	2015
contenttype_str_mv	txt
container_start_page	125
author_browse	Khalifa E. Sharquie Sabeeh A. Al-Mashhadani Adil A. Noaimi Wasan B. Al-Zoubaidi
container_volume	6
class	RL1-803
format_se	Elektronische Aufsätze
author-letter	Khalifa E. Sharquie
doi_str_mv	10.7241/ourd.20152.34
author2-role	verfasserin
title_sort	microwave thermotherapy: new treatment for cutaneous leishmaniasis
callnumber	RL1-803
title_auth	Microwave Thermotherapy: New treatment for cutaneous leishmaniasis
abstract	Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects.
abstractGer	Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects.
abstract_unstemmed	Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	2
title_short	Microwave Thermotherapy: New treatment for cutaneous leishmaniasis
url	https://doi.org/10.7241/ourd.20152.34 https://doaj.org/article/cb2fe83f000a443cb8fa9d3c25b45866 http://www.odermatol.com/issue-in-html/2015-2-1/ https://doaj.org/toc/2081-9390
remote_bool	true
author2	Sabeeh A. Al-Mashhadani Adil A. Noaimi Wasan B. Al-Zoubaidi
author2Str	Sabeeh A. Al-Mashhadani Adil A. Noaimi Wasan B. Al-Zoubaidi
ppnlink	1760606286
callnumber-subject	RL - Dermatology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.7241/ourd.20152.34
callnumber-a	RL1-803
up_date	2024-07-03T17:09:14.826Z
_version_	1803578564755324928
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ065895401</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309053933.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7241/ourd.20152.34</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ065895401</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJcb2fe83f000a443cb8fa9d3c25b45866</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">spa</subfield><subfield code="a">fre</subfield><subfield code="a">pol</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RL1-803</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Khalifa E. Sharquie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Microwave Thermotherapy: New treatment for cutaneous leishmaniasis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction: Cutaneous leishmaniasis(CL) is an endemic disease with variable therapeutic agents. Microwave radiation has been used in many medical disciplines as therapeutic and diagnostic tools. Objective: To evaluate the efficacy of microwave radiofrequency in the treatment of cutaneous leishmaniasis. Patients and methods: This is a case, controlled, therapeutic, clinical trial. Thirty five patients completed the study, 18 (51.43%) females and 17 (48.57%) males, with female to male ratio 1.1:1, their ages ranged from 6–60 (26.98±15.22) years and the duration of lesions ranged between 1–6 (2.17±1.44) months. The size of lesions ranged from 1-6.5 (2.87±1.60) cm. Eleven (31.43%) patients had single lesion and 24 (68.57%) patients had multiple lesions. Classical cases of CL were studied and diagnosis was confirmed by histopathological examination. Lesions had been divided in 2 groups, Group A: lesions were exposed to a microwave radiation once every two weeks for a maximum of 8 weeks, while Group B lesions, received no treatment and left as a control group. Patients were seen every 2 weeks for 8 weeks to reassess the therapeutic effect and to record any side effects. Follow up after cure was carried out for 2-6 months to watch any sign of relapse. Results: The total number of lesions were 99;52 (52.53%) ulcerated lesions and 47 (47.47%) dry lesions. In Group A, 64 (85.33%) lesions out of 75 showed clinical cure with 1-4 (2.77±0.91) sessions while in Group B, 5 (20.83%) lesions out of 24 lesions showed slight healing during the treatment period. No side effects appear in all patients. Conclusion: Microwave thermotherapy is highly effective, new therapy for cutaneous leishmaniasis with no harmful side effects.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cutaneous leishmaniasis; Thermotherapy; Microwave</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Dermatology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sabeeh A. Al-Mashhadani</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Adil A. Noaimi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wasan B. Al-Zoubaidi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nasza Dermatologia Online</subfield><subfield code="d">Our Dermatology Online, 2011</subfield><subfield code="g">6(2015), 2, Seite 125-129</subfield><subfield code="w">(DE-627)1760606286</subfield><subfield code="x">20819390</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:6</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:125-129</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.7241/ourd.20152.34</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/cb2fe83f000a443cb8fa9d3c25b45866</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.odermatol.com/issue-in-html/2015-2-1/</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2081-9390</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">6</subfield><subfield code="j">2015</subfield><subfield code="e">2</subfield><subfield code="h">125-129</subfield></datafield></record></collection>
score	7.402793

Nicht das Richtige dabei?

Schreiben Sie uns!

Microwave Thermotherapy: New treatment for cutaneous leishmaniasis

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?